924:
Mantovani, G; Bastepe, M; Monk, D; de
Sanctis, L; Thiele, S; Usardi, A; Ahmed, SF; Bufo, R; Choplin, T; De Filippo, G; Devernois, G; Eggermann, T; Elli, FM; Freson, K; GarcĂa Ramirez, A; Germain-Lee, EL; Groussin, L; Hamdy, N; Hanna, P; Hiort, O; JĂźppner, H; KamenickĂ˝, P; Knight, N; Kottler, ML; Le
925:
Norcy, E; Lecumberri, B; Levine, MA; Mäkitie, O; Martin, R; Martos-Moreno, GĂ; Minagawa, M; Murray, P; Pereda, A; Pignolo, R; Rejnmark, L; Rodado, R; Rothenbuhler, A; Saraff, V; Shoemaker, AH; Shore, EM; Silve, C; Turan, S; Woods, P; Zillikens, MC; Perez de
Nanclares, G; Linglart, A (August 2018).
1008:
993:
165:). The phenotype is the same as in type 1a, but red blood cells show normal Gs activity. As it is also caused by a GNAS mutation, it is not clear whether it should be considered an entity separate from Ia.
1237:
1729:
1946:
671:"Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance"
1865:
1585:
1230:
1289:
62:, but the parathyroid hormone level (PTH) is inappropriately high (due to the low level of calcium in the blood). Its pathogenesis has been linked to dysfunctional
70:). Pseudohypoparathyroidism is a very rare disorder, with estimated prevalence between 0.3 and 1.1 cases per 100,000 population depending on geographic location.
1125:
889:
2039:
1330:
2177:
1746:
1223:
150:
Also lacks the physical appearance of type 1a. Since the genetic defect in type 2 is further down the signalling pathway than in type 1, there is a normal
1742:
1314:
1995:
1771:
1646:
193:
is typically mildly depressed or unaffected. Additional characteristics include short stature, obesity, developmental delay, and calcification of the
158:
While biochemically similar, type 1 and 2 disease may be distinguished by the differing urinary excretion of cyclic AMP in response to exogenous PTH.
1612:
1397:
1831:
1374:
1325:
404:
315:
93:
1783:
1650:
1626:
865:
830:
542:
2065:
1971:
1886:
1848:
1443:
1420:
1539:
1511:
1495:
1023:
750:
653:
597:
1621:
1958:
1734:
1294:
1118:
2032:
1819:
1807:
2087:
615:"Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy"
2006:
1936:
1689:
1302:
1573:
2155:
1757:
1601:
1362:
1155:
486:
399:
237:
151:
1941:
1904:
1178:
1870:
1183:
1111:
154:
response to PTH stimulation despite the inherent abnormality in calcium regulation. The specific gene is not identified.
2091:
2025:
1983:
1173:
712:"Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16"
109:
1858:
1532:
1520:
927:"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement"
896:
1921:
1704:
1255:
216:
of the hand is viewed in closed fist position. This presentation is known as 'knuckle knuckle dimple dimple' sign (
2132:
1795:
1369:
1350:
1282:
208:
Type 1a pseudohypoparathyroidism is clinically manifest by bone resorption with blunting of the fourth and fifth
1664:
1712:
1474:
1415:
1188:
1040:
1717:
1552:
472:
Calcium and
Calcitriol supplements, the latter with a larger dose than for treatment of hypoparathyroidism.
2182:
1464:
1458:
1298:
926:
670:
2143:
2120:
2075:
1925:
1318:
1246:
190:
2057:
1346:
1277:
1660:
1656:
1337:
1165:
1134:
1012:
491:
453:
449:
256:
217:
51:
2106:
2049:
1634:
1142:
791:
501:
481:
284:
277:
105:
47:
810:
522:
2128:
1675:
1548:
1524:
1504:
1500:
1080:
1051:
959:
861:
855:
836:
826:
783:
733:
692:
636:
573:
548:
538:
443:
30:
1568:
1563:
1528:
1488:
1260:
949:
941:
818:
775:
723:
682:
626:
530:
213:
101:
67:
1556:
1204:
221:
133:
similar. It is associated with a methylation defect in the A/B exon of GNAS1, caused by
1882:
1790:
1722:
1544:
1516:
1017:
954:
2017:
2171:
1890:
1580:
1342:
1215:
225:
194:
174:
35:
795:
1899:
1826:
1309:
1091:
438:
198:
1045:
1075:
822:
817:. Advances in Experimental Medicine and Biology. Vol. 626. pp. 27â40.
779:
567:
534:
529:. Advances in Experimental Medicine and Biology. Vol. 626. pp. 27â40.
130:
97:
1056:
1597:
1002:
945:
766:
Aldred MA (May 2006). "Genetics of pseudohypoparathyroidism types Ia and Ic".
460:
272:
262:
241:
209:
244:
appearance of pseudohypoparathyroidism type 1a, but is biochemically normal.
1814:
1802:
1778:
1086:
63:
59:
963:
840:
787:
737:
696:
640:
577:
552:
890:"Pseudohypoparathyroidism: A Variation on the Theme of Hypoparathyroidism"
1932:
1766:
1638:
728:
711:
687:
631:
614:
613:
de
Nanclares GP, FernĂĄndez-Rebollo E, Santin I, et al. (June 2007).
186:
496:
267:
55:
1103:
985:
710:
FrĂśhlich LF, Bastepe M, Ozturk D, Abu-Zahra H, JĂźppner H (June 2007).
1978:
1684:
1642:
997:
182:
224:
which is characterized by blunting of only the fourth knuckle, and
1990:
1966:
1592:
1392:
1357:
368:
364:
360:
333:
202:
178:
134:
113:
1953:
1877:
1853:
1483:
1438:
1034:
1031:
1028:
754:
657:
601:
162:
143:
122:
85:
2021:
1219:
1107:
854:
Shahid
Hussain; Sharif Aaron Latif; Adrian Hall (1 July 2010).
566:
Ucciferro, Peter; Anastasolpoulou, Catherine (10 August 2020).
367:) however it can also be the result of an imprinting issue of (
50:
genetic condition associated primarily with resistance to the
669:
Laspa E, Bastepe M, JĂźppner H, Tsatsoulis A (December 2004).
240:
is used to describe a condition where the individual has the
228:, which is associated with a hypoplastic middle phalanx.
246:
1947:
Junctional epidermolysis bullosa with pyloric atresia
975:
185:, and if the calcium deficit is severe, generalized
2142:
2119:
2074:
2056:
1914:
1841:
1756:
1703:
1674:
1611:
1473:
1457:
1430:
1407:
1384:
1269:
1254:
1197:
1164:
1141:
1066:
979:
29:
24:
129:Lacks the physical appearance of type 1a, but is
1586:Congenital insensitivity to pain with anhidrosis
572:. Treasure Island (FL): StatPearls Publishing.
161:Some sources also refer to a "type 1c" (OMIM
2033:
1231:
1119:
811:"The GNAS Locus and Pseudohypoparathyroidism"
523:"The GNAS Locus and Pseudohypoparathyroidism"
8:
1331:Gonadotropin-releasing hormone insensitivity
371:) due to mother and father in equal measure
92:Has a characteristic phenotypic appearance (
54:. Those with the condition have a low serum
1747:Congenital amegakaryocytic thrombocytopenia
2080:
2040:
2026:
2018:
1832:Autoimmune lymphoproliferative syndrome 1A
1470:
1315:Follicle-stimulating hormone insensitivity
1266:
1238:
1224:
1216:
1126:
1112:
1104:
976:
21:
1996:X-linked severe combined immunodeficiency
1772:TNF receptor associated periodic syndrome
953:
727:
686:
630:
1784:Selective immunoglobulin A deficiency 2
1375:Aspirin-exacerbated respiratory disease
513:
1959:EDAR hypohidrotic ectodermal dysplasia
1887:Familial exudative vitreoretinopathy 4
1444:Familial exudative vitreoretinopathy 1
173:Patients may present with features of
1651:Hereditary hemorrhagic telangiectasia
1627:Persistent MĂźllerian duct syndrome II
1398:Jansen's metaphyseal chondrodysplasia
108:disorder. It is also associated with
7:
2066:Transient neonatal diabetes mellitus
1972:Nevoid basal-cell carcinoma syndrome
1421:Familial hypocalciuric hypercalcemia
860:. Manson Publishing. pp. 262â.
96:), including short fourth and fifth
94:Albright's hereditary osteodystrophy
1735:Surfactant metabolism dysfunction 4
751:Online Mendelian Inheritance in Man
654:Online Mendelian Inheritance in Man
598:Online Mendelian Inheritance in Man
212:of the hand, most notable when the
2178:Cell surface receptor deficiencies
1984:BMPR1A juvenile polyposis syndrome
1905:LDLR Familial hypercholesterolemia
359:Likely a gene defect from mother (
14:
1295:Luteinizing hormone insensitivity
1363:Nephrogenic diabetes insipidus 1
1303:Male-limited precocious puberty
177:including carpo-pedal muscular
2156:Pseudopseudohypoparathyroidism
1690:Leber's congenital amaurosis 1
1602:Gastrointestinal stromal tumor
1156:Pseudopseudohypoparathyroidism
487:Pseudopseudohypoparathyroidism
400:Pseudopseudohypoparathyroidism
238:pseudopseudohypoparathyroidism
1:
934:Nature Reviews. Endocrinology
768:J. Pediatr. Endocrinol. Metab
375:
340:
311:
2088:BeckwithâWiedemann syndrome
1283:Congenital hypothyroidism 1
823:10.1007/978-0-387-77576-0_3
780:10.1515/jpem.2006.19.s2.635
535:10.1007/978-0-387-77576-0_3
110:thyroid stimulating hormone
2199:
1942:Glanzmann's thrombasthenia
1922:Immunoglobulin superfamily
1574:RabsonâMendenhall syndrome
1256:G protein-coupled receptor
675:J. Clin. Endocrinol. Metab
619:J. Clin. Endocrinol. Metab
2102:
2083:
1796:Hyper-IgM syndrome type 3
946:10.1038/s41574-018-0042-0
857:Rapid Review of Radiology
398:
332:Gene defect from mother (
309:Pseudohypoparathyroidism
308:
283:
249:
220:). This is as opposed to
2152:Pseudohypoparathyroidism
1871:CenaniâLenz syndactylism
1713:Type I cytokine receptor
1351:Hirschsprung's disease 2
1189:Osteitis fibrosa cystica
1151:Pseudohypoparathyroidism
569:Pseudohypoparathyroidism
421:gene defect from father
44:Pseudohypoparathyroidism
25:Pseudohypoparathyroidism
2092:SilverâRussell syndrome
1553:Thanatophoric dysplasia
1347:Waardenburg syndrome 4a
104:. It is most likely an
2007:cell surface receptors
1859:DonnaiâBarrow syndrome
1533:JacksonâWeiss syndrome
1521:AntleyâBixler syndrome
1505:KAL2 Kallmann syndrome
1459:Enzyme-linked receptor
1299:Leydig cell hypoplasia
112:resistance. Caused by
16:Rare genetic condition
2133:Prader-Willi syndrome
1319:XX gonadal dysgenesis
1247:Cell surface receptor
1665:LoeysâDietz syndrome
729:10.1210/en.2006-1298
688:10.1210/jc.2004-0249
632:10.1210/jc.2006-2287
433:Biochemical findings
1166:Hyperparathyroidism
1135:Parathyroid disease
809:Bastepe, M (2008).
774:(Suppl 2): 635â40.
492:Hyperparathyroidism
454:hyperparathyroidism
450:parathyroid hormone
52:parathyroid hormone
2107:Myoclonic dystonia
2050:genomic imprinting
1635:TGF beta receptors
1143:Hypoparathyroidism
1067:External resources
815:Genomic Imprinting
527:Genomic Imprinting
521:Bastepe M (2008).
502:Hypervitaminosis D
482:Hypoparathyroidism
285:Hypoparathyroidism
232:Related conditions
106:autosomal dominant
48:autosomal dominant
2165:
2164:
2129:Angelman syndrome
2115:
2114:
2048:Disorders due to
2015:
2014:
1699:
1698:
1549:Hypochondroplasia
1525:Pfeiffer syndrome
1501:Pfeiffer syndrome
1453:
1452:
1213:
1212:
1101:
1100:
888:Levine, Michael.
867:978-1-84076-120-7
832:978-0-387-77575-3
544:978-0-387-77575-3
444:hyperphosphatemia
425:
424:
41:
40:
19:Medical condition
2190:
2081:
2042:
2035:
2028:
2019:
1569:Donohue syndrome
1529:Crouzon syndrome
1489:Robinow syndrome
1471:
1267:
1240:
1233:
1226:
1217:
1128:
1121:
1114:
1105:
977:
967:
957:
931:
911:
910:
908:
907:
901:
895:. Archived from
894:
885:
879:
878:
876:
874:
851:
845:
844:
806:
800:
799:
763:
757:
748:
742:
741:
731:
707:
701:
700:
690:
666:
660:
651:
645:
644:
634:
610:
604:
595:
589:
588:
586:
584:
563:
557:
556:
518:
405:Skeletal defects
316:Skeletal defects
247:
218:Archibald's sign
147:
126:
89:
68:Gs alpha subunit
66:(in particular,
22:
2198:
2197:
2193:
2192:
2191:
2189:
2188:
2187:
2168:
2167:
2166:
2161:
2138:
2111:
2098:
2095:
2070:
2052:
2046:
2016:
2011:
1915:Other/ungrouped
1910:
1891:Osteopetrosis 1
1837:
1752:
1695:
1670:
1607:
1557:Muenke syndrome
1463:
1461:
1449:
1426:
1403:
1380:
1258:
1250:
1244:
1214:
1209:
1205:Parathyroiditis
1193:
1160:
1137:
1132:
1102:
1097:
1096:
1062:
1061:
988:
974:
929:
923:
920:
918:Further reading
915:
914:
905:
903:
899:
892:
887:
886:
882:
872:
870:
868:
853:
852:
848:
833:
808:
807:
803:
765:
764:
760:
749:
745:
709:
708:
704:
668:
667:
663:
652:
648:
612:
611:
607:
596:
592:
582:
580:
565:
564:
560:
545:
520:
519:
515:
510:
478:
470:
435:
430:
304:Not applicable
234:
222:Turner syndrome
171:
141:
120:
83:
78:Types include:
76:
20:
17:
12:
11:
5:
2196:
2194:
2186:
2185:
2180:
2170:
2169:
2163:
2162:
2160:
2159:
2148:
2146:
2140:
2139:
2137:
2136:
2125:
2123:
2117:
2116:
2113:
2112:
2110:
2109:
2103:
2100:
2099:
2097:
2096:
2084:
2078:
2072:
2071:
2069:
2068:
2062:
2060:
2054:
2053:
2047:
2045:
2044:
2037:
2030:
2022:
2013:
2012:
2010:
2009:
2004:
2000:
1999:
1987:
1975:
1950:
1949:
1944:
1939:
1929:
1928:
1918:
1916:
1912:
1911:
1909:
1908:
1895:
1894:
1883:Worth syndrome
1874:
1862:
1845:
1843:
1842:Lipid receptor
1839:
1838:
1836:
1835:
1823:
1811:
1799:
1787:
1775:
1762:
1760:
1754:
1753:
1751:
1750:
1739:
1738:
1726:
1723:Laron syndrome
1709:
1707:
1701:
1700:
1697:
1696:
1694:
1693:
1680:
1678:
1672:
1671:
1669:
1668:
1654:
1631:
1630:
1617:
1615:
1609:
1608:
1606:
1605:
1598:KIT Piebaldism
1589:
1577:
1571:
1560:
1545:Achondroplasia
1536:
1517:Apert syndrome
1508:
1492:
1479:
1477:
1468:
1455:
1454:
1451:
1450:
1448:
1447:
1434:
1432:
1428:
1427:
1425:
1424:
1411:
1409:
1405:
1404:
1402:
1401:
1388:
1386:
1382:
1381:
1379:
1378:
1366:
1354:
1334:
1322:
1306:
1286:
1273:
1271:
1264:
1252:
1251:
1245:
1243:
1242:
1235:
1228:
1220:
1211:
1210:
1208:
1207:
1201:
1199:
1195:
1194:
1192:
1191:
1186:
1181:
1176:
1170:
1168:
1162:
1161:
1159:
1158:
1153:
1147:
1145:
1139:
1138:
1133:
1131:
1130:
1123:
1116:
1108:
1099:
1098:
1095:
1094:
1083:
1071:
1070:
1068:
1064:
1063:
1060:
1059:
1048:
1037:
1020:
1005:
989:
984:
983:
981:
980:Classification
973:
972:External links
970:
969:
968:
940:(8): 476â500.
919:
916:
913:
912:
880:
866:
846:
831:
801:
758:
743:
722:(6): 2925â35.
702:
681:(12): 5942â7.
661:
646:
605:
590:
558:
543:
512:
511:
509:
506:
505:
504:
499:
494:
489:
484:
477:
474:
469:
466:
465:
464:
457:
446:
441:
434:
431:
429:
426:
423:
422:
419:
416:
413:
410:
407:
402:
396:
395:
392:
389:
386:
383:
380:
377:
373:
372:
357:
354:
351:
348:
345:
342:
338:
337:
330:
327:
324:
321:
318:
313:
310:
306:
305:
302:
299:
296:
293:
290:
287:
281:
280:
275:
270:
265:
260:
254:
251:
233:
230:
170:
167:
156:
155:
148:
138:
127:
117:
100:and a rounded
90:
75:
72:
39:
38:
33:
27:
26:
18:
15:
13:
10:
9:
6:
4:
3:
2:
2195:
2184:
2183:Rare diseases
2181:
2179:
2176:
2175:
2173:
2157:
2153:
2150:
2149:
2147:
2145:
2144:Chromosome 20
2141:
2134:
2130:
2127:
2126:
2124:
2122:
2121:Chromosome 15
2118:
2108:
2105:
2104:
2101:
2093:
2089:
2086:
2085:
2082:
2079:
2077:
2076:Chromosome 11
2073:
2067:
2064:
2063:
2061:
2059:
2055:
2051:
2043:
2038:
2036:
2031:
2029:
2024:
2023:
2020:
2008:
2005:
2002:
2001:
1997:
1993:
1992:
1988:
1985:
1981:
1980:
1976:
1973:
1969:
1968:
1964:
1963:
1962:
1960:
1956:
1955:
1948:
1945:
1943:
1940:
1938:
1934:
1931:
1930:
1927:
1923:
1920:
1919:
1917:
1913:
1906:
1902:
1901:
1897:
1896:
1892:
1888:
1884:
1880:
1879:
1875:
1872:
1868:
1867:
1863:
1860:
1856:
1855:
1850:
1847:
1846:
1844:
1840:
1833:
1829:
1828:
1824:
1821:
1817:
1816:
1812:
1809:
1805:
1804:
1800:
1797:
1793:
1792:
1788:
1785:
1781:
1780:
1776:
1773:
1769:
1768:
1764:
1763:
1761:
1759:
1755:
1748:
1744:
1741:
1740:
1736:
1732:
1731:
1727:
1724:
1720:
1719:
1714:
1711:
1710:
1708:
1706:
1702:
1691:
1687:
1686:
1682:
1681:
1679:
1677:
1673:
1666:
1662:
1658:
1655:
1652:
1648:
1644:
1640:
1636:
1633:
1632:
1628:
1624:
1623:
1619:
1618:
1616:
1614:
1610:
1603:
1599:
1595:
1594:
1590:
1587:
1583:
1582:
1578:
1575:
1572:
1570:
1566:
1565:
1561:
1558:
1554:
1550:
1546:
1542:
1541:
1537:
1534:
1530:
1526:
1522:
1518:
1514:
1513:
1509:
1506:
1502:
1498:
1497:
1493:
1490:
1486:
1485:
1481:
1480:
1478:
1476:
1472:
1469:
1466:
1465:growth factor
1460:
1456:
1445:
1441:
1440:
1436:
1435:
1433:
1429:
1422:
1418:
1417:
1413:
1412:
1410:
1406:
1399:
1395:
1394:
1390:
1389:
1387:
1383:
1376:
1372:
1371:
1367:
1364:
1360:
1359:
1355:
1352:
1348:
1344:
1343:ABCD syndrome
1340:
1339:
1335:
1332:
1328:
1327:
1323:
1320:
1316:
1312:
1311:
1307:
1304:
1300:
1296:
1292:
1291:
1287:
1284:
1280:
1279:
1275:
1274:
1272:
1268:
1265:
1262:
1257:
1253:
1248:
1241:
1236:
1234:
1229:
1227:
1222:
1221:
1218:
1206:
1203:
1202:
1200:
1196:
1190:
1187:
1185:
1182:
1180:
1177:
1175:
1172:
1171:
1169:
1167:
1163:
1157:
1154:
1152:
1149:
1148:
1146:
1144:
1140:
1136:
1129:
1124:
1122:
1117:
1115:
1110:
1109:
1106:
1093:
1089:
1088:
1084:
1082:
1078:
1077:
1073:
1072:
1069:
1065:
1058:
1054:
1053:
1049:
1047:
1043:
1042:
1038:
1036:
1033:
1030:
1026:
1025:
1021:
1019:
1015:
1014:
1010:
1006:
1004:
1000:
999:
995:
991:
990:
987:
982:
978:
971:
965:
961:
956:
951:
947:
943:
939:
935:
928:
922:
921:
917:
902:on 2016-03-04
898:
891:
884:
881:
869:
863:
859:
858:
850:
847:
842:
838:
834:
828:
824:
820:
816:
812:
805:
802:
797:
793:
789:
785:
781:
777:
773:
769:
762:
759:
756:
752:
747:
744:
739:
735:
730:
725:
721:
717:
716:Endocrinology
713:
706:
703:
698:
694:
689:
684:
680:
676:
672:
665:
662:
659:
655:
650:
647:
642:
638:
633:
628:
625:(6): 2370â3.
624:
620:
616:
609:
606:
603:
599:
594:
591:
579:
575:
571:
570:
562:
559:
554:
550:
546:
540:
536:
532:
528:
524:
517:
514:
507:
503:
500:
498:
495:
493:
490:
488:
485:
483:
480:
479:
475:
473:
467:
462:
458:
455:
451:
447:
445:
442:
440:
437:
436:
432:
427:
420:
417:
414:
411:
408:
406:
403:
401:
397:
393:
390:
387:
384:
381:
378:
374:
370:
366:
362:
358:
355:
352:
349:
346:
343:
339:
335:
331:
328:
325:
322:
319:
317:
314:
307:
303:
300:
297:
294:
291:
288:
286:
282:
279:
276:
274:
271:
269:
266:
264:
261:
258:
255:
252:
248:
245:
243:
239:
231:
229:
227:
226:Down syndrome
223:
219:
215:
211:
206:
204:
200:
196:
195:basal ganglia
192:
188:
184:
180:
176:
175:hypocalcaemia
168:
166:
164:
159:
153:
149:
145:
139:
136:
132:
131:biochemically
128:
124:
118:
115:
111:
107:
103:
99:
95:
91:
87:
81:
80:
79:
73:
71:
69:
65:
61:
57:
53:
49:
45:
37:
36:Endocrinology
34:
32:
28:
23:
2151:
2058:Chromosome 6
1989:
1977:
1965:
1952:
1951:
1898:
1876:
1864:
1852:
1825:
1813:
1801:
1789:
1777:
1765:
1758:TNF receptor
1728:
1716:
1683:
1620:
1591:
1579:
1562:
1538:
1510:
1494:
1482:
1437:
1414:
1391:
1368:
1356:
1336:
1324:
1308:
1288:
1276:
1249:deficiencies
1150:
1085:
1074:
1050:
1039:
1022:
1007:
992:
937:
933:
904:. Retrieved
897:the original
883:
871:. Retrieved
856:
849:
814:
804:
771:
767:
761:
746:
719:
715:
705:
678:
674:
664:
649:
622:
618:
608:
593:
581:. Retrieved
568:
561:
526:
516:
471:
439:hypocalcemia
235:
207:
199:white matter
197:in the deep
181:, cramping,
172:
169:Presentation
160:
157:
77:
43:
42:
1259:(including
1076:MedlinePlus
459:Suppressed
253:Appearance
137:disruption.
98:metacarpals
2172:Categories
1462:(including
1052:DiseasesDB
906:2014-11-10
873:30 October
508:References
461:calcitriol
278:Imprinting
273:Phosphates
263:Calcitriol
250:Condition
242:phenotypic
64:G proteins
46:is a rare
1815:TNFRSF13B
1803:TNFRSF13C
1779:TNFRSF13B
1179:Secondary
1087:eMedicine
468:Treatment
448:elevated
428:Diagnosis
236:The term
116:mutation.
60:phosphate
58:and high
31:Specialty
2003:See also
1933:Integrin
1767:TNFRSF1A
1705:JAK-STAT
1639:Endoglin
1184:Tertiary
1092:med/1940
964:29959430
841:18372789
796:26538688
788:16789628
753:(OMIM):
738:17317779
697:15579741
656:(OMIM):
641:17405843
600:(OMIM):
578:31613489
553:18372789
476:See also
341:Type 1B
312:Type 1A
210:knuckles
187:seizures
119:Type 1b
82:Type 1a
1926:AGM3, 6
1827:TNFRSF6
1791:TNFRSF5
1431:Class F
1408:Class C
1385:Class B
1270:Class A
1261:hormone
1174:Primary
1046:D011547
955:6541219
497:Rickets
418:Normal
415:Normal
412:Normal
409:Normal
379:Normal
376:Type 2
344:Normal
289:Normal
268:Calcium
259:levels
201:of the
142:(OMIM
140:Type 2
121:(OMIM
84:(OMIM
56:calcium
1979:BMPR1A
1730:CSF2RA
1685:GUCY2D
1661:TGFBR2
1657:TGFBR1
1370:PTGER2
1081:000364
1035:203330
1032:603233
1029:103580
1018:275.49
962:
952:
864:
839:
829:
794:
786:
755:203330
736:
695:
658:603233
639:
602:103580
576:
551:
541:
463:levels
214:dorsum
183:tetany
179:spasms
163:612462
144:203330
123:603233
102:facies
86:103580
1991:IL2RG
1967:PTCH1
1820:CVID2
1808:CVID4
1647:SMAD4
1643:Alk-1
1622:AMHR2
1581:NTRK1
1540:FGFR3
1512:FGFR2
1496:FGFR1
1393:PTH1R
1358:AVPR2
1338:EDNRB
1326:GnRHR
1290:LHCGR
1198:Other
1057:10835
1003:E20.1
930:(PDF)
900:(PDF)
893:(PDF)
792:S2CID
583:2 May
391:High
382:High
369:GNAS1
365:STX16
361:GNAS1
356:High
347:High
334:GNAS1
329:High
320:High
301:High
203:brain
135:STX16
114:GNAS1
74:Types
2154:â /
2131:â /
2090:â /
1954:EDAR
1937:LAD1
1900:LDLR
1878:LRP5
1866:LRP4
1854:LRP2
1613:STPK
1564:INSR
1484:ROR2
1439:FZD4
1416:CASR
1310:FSHR
1278:TSHR
1041:MeSH
1024:OMIM
1013:9-CM
960:PMID
875:2010
862:ISBN
837:PMID
827:ISBN
784:PMID
734:PMID
693:PMID
637:PMID
585:2021
574:PMID
549:PMID
539:ISBN
388:Low
385:Low
363:and
353:Low
350:Low
326:Low
323:Low
298:Low
295:Low
292:Low
152:cAMP
1849:LRP
1743:MPL
1593:KIT
1475:RTK
1009:ICD
994:ICD
950:PMC
942:doi
819:doi
776:doi
724:doi
720:148
683:doi
627:doi
531:doi
257:PTH
2174::
1961:)
1935::
1924::
1889:,
1885:,
1851::
1718:GH
1715::
1676:GC
1637::
1600:,
1555:,
1551:,
1547:,
1531:,
1527:,
1523:,
1519:,
1503:,
1349:,
1345:,
1317:,
1301:,
1297:,
1090::
1079::
1055::
1044::
1027::
1016::
1001::
998:10
958:.
948:.
938:14
936:.
932:.
835:.
825:.
813:.
790:.
782:.
772:19
770:.
732:.
718:.
714:.
691:.
679:89
677:.
673:.
635:.
623:92
621:.
617:.
547:.
537:.
525:.
394:?
336:)
205:.
191:IQ
189:.
2158:â
2135:â
2094:â
2041:e
2034:t
2027:v
1998:)
1994:(
1986:)
1982:(
1974:)
1970:(
1957:(
1907:)
1903:(
1893:)
1881:(
1873:)
1869:(
1861:)
1857:(
1834:)
1830:(
1822:)
1818:(
1810:)
1806:(
1798:)
1794:(
1786:)
1782:(
1774:)
1770:(
1749:)
1745:(
1737:)
1733:(
1725:)
1721:(
1692:)
1688:(
1667:)
1663:(
1659:/
1653:)
1649:(
1645:/
1641:/
1629:)
1625:(
1604:)
1596:(
1588:)
1584:(
1576:)
1567:(
1559:)
1543:(
1535:)
1515:(
1507:)
1499:(
1491:)
1487:(
1467:)
1446:)
1442:(
1423:)
1419:(
1400:)
1396:(
1377:)
1373:(
1365:)
1361:(
1353:)
1341:(
1333:)
1329:(
1321:)
1313:(
1305:)
1293:(
1285:)
1281:(
1263:)
1239:e
1232:t
1225:v
1127:e
1120:t
1113:v
1011:-
996:-
986:D
966:.
944::
909:.
877:.
843:.
821::
798:.
778::
740:.
726::
699:.
685::
643:.
629::
587:.
555:.
533::
456:)
452:(
146:)
125:)
88:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.